Back to Gastroenterology
Gastroenterologyv2014Evidence-Based

CLIF-C ACLF (Acute-on-Chronic Liver Failure)

Predicts mortality in acute-on-chronic liver failure patients

Clinical Input Parameters

years
Range: 18 — 100 years
×10⁹ cells/L
Range: 0.1 — 100 ×10⁹ cells/L
mg/dL
Range: 0.1 — 50 mg/dL
mg/dL
Range: 0.1 — 20 mg/dL
Range: 0.5 — 10
mmHg
Range: 30 — 150 mmHg
Range: 50 — 600
Clinical Assessment
Awaiting Parameters
clif c aclf score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The CLIF-C ACLF (Acute-on-Chronic Liver Failure) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

CLIF-C ACLF Score = 10 × [0.33 × CLIF-C OF Score + 0.04 × age + 0.63 × ln(WBC count) - 2]. CLIF-C OF Score based on 6 organ systems: liver (bilirubin), kidney (creatinine/RRT), brain (hepatic encephalopathy), coagulation (INR), circulatory (MAP/vasopressors), respiratory (PaO2/FiO2 or SpO2/FiO2).

Clinical Pearls & Practice Notes

  • Specifically designed for patients with acute-on-chronic liver failure (ACLF)
  • Superior to MELD, MELD-Na, and Child-Pugh scores for mortality prediction in ACLF
  • Score ≥70 associated with 100% mortality at 28 days
  • Score ≥65 at 3-7 days after ACLF diagnosis indicates very poor prognosis
  • Predicts mortality at 1, 3, 6, and 12 months
  • Based on the CANONIC study (EASL-CLIF Acute-on-Chronic Liver Failure in Cirrhosis)
  • Should be used in conjunction with clinical judgment for treatment decisions
  • Helps guide decisions regarding intensive care admission and liver transplantation eligibility

Evidence & Literature Citations

  1. Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, Hopf C, Alessandria C, Rodriguez E, Solis-Muñoz P, Laleman W, Trebicka J, Zeuzem S, Gustot T, Mookerjee R, Elkrief L, Soriano G, Cordoba J, Morando F, Gerbes A, Agarwal B, Samuel D, Bernardi M, Arroyo V; CANONIC study investigators of the EASL-Clif Consortium. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol. 2014;61(5):1038-47.
  2. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL-Clif Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144(7):1426-37.

Score Interpretation Ranges

Low Risk0 – 45 pts

Lower mortality risk

Moderate Risk45 – 65 pts

Moderate mortality risk

High Risk65 – 70 pts

High mortality risk

Critical Risk70 – 100 pts

Critical mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.